Literature DB >> 19909342

Early production of tumor necrosis factor-alpha by Gr-1 cells and its role in the host defense to pneumococcal infection in lungs.

Masumitsu Hatta1, Natsuo Yamamoto, Akiko Miyazato, Naoto Ishii, Kiwamu Nakamura, Ken Inden, Tetsuji Aoyagi, Hiroyuki Kunishima, Yoichi Hirakata, Kazuo Suzuki, Mitsuo Kaku, Kazuyoshi Kawakami.   

Abstract

In this study, we elucidated the role of tumor necrosis factor (TNF)-alpha in the host defense to pulmonary infection with Streptococcus pneumoniae and defined the cellular source of this cytokine at an early stage of infection. Administration of anti-TNF-alpha monoclonal antibody (mAb) resulted in the reduced accumulation of neutrophils in bronchoalveolar lavage fluids (BALFs) and severe exacerbation of this infection. In a flow cytometric analysis, the intracellular expression of TNF-alpha was detected in Gr-1(bright+) and Gr-1(dull+) cells during the time intervals postinfection, and F4/80(+) cells expressed intracellular TNF-alpha before Gr-1(dull+) cells appeared. The Gr-1(bright+) and Gr-1(dull+) cells sorted from BALF cells at 24 h were identified as neutrophils and macrophage-like cells, respectively, and the Gr-1(dull+) cells expressing CD11c, partially CD11b and a marginal level of F4/80 secreted TNF-alpha in in vitro cultures. Finally, deletion of Gr-1(+) cells by administration of the specific mAb significantly reduced the concentrations of this cytokine in BALF at 6 and 12 h postinfection, but not the expression of TNF-alpha in F4/80(+) cells. Thus, these results demonstrated that neutrophils, F4/80(+) macrophages and Gr-1(dull+) CD11c(+) macrophage-like cells played an important role in the production of TNF-alpha in lungs at an early stage of infection with S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909342     DOI: 10.1111/j.1574-695X.2009.00616.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  5 in total

1.  Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation.

Authors:  Robert M Tighe; Zhuowei Li; Erin N Potts; Sarah Frush; Ningshan Liu; Michael D Gunn; W Michael Foster; Paul W Noble; John W Hollingsworth
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

Review 2.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Difference in Resistance to Streptococcus pneumoniae Infection in Mice.

Authors:  Dong-Gu Jeong; Eui-Suk Jeong; Jin-Hee Seo; Seung-Ho Heo; Yang-Kyu Choi
Journal:  Lab Anim Res       Date:  2011-06-22

4.  Regulation of monocyte subset proinflammatory responses within the lung microvasculature by the p38 MAPK/MK2 pathway.

Authors:  Kieran P O'Dea; Justina O Dokpesi; Kate C Tatham; Michael R Wilson; Masao Takata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

5.  Tumor necrosis factor-alpha deficiency impairs host defense against Streptococcus pneumoniae.

Authors:  Dong-Gu Jeong; Jin-Hee Seo; Seung-Ho Heo; Yang-Kyu Choi; Eui-Suk Jeong
Journal:  Lab Anim Res       Date:  2015-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.